Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization, workflow efficiency, and multispecialty flexibility ...

The patent’s assignee is AntiCancer, Inc. News editors obtained the following quote from the background information supplied by the inventors: “This invention relates to the use of a portable ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start ...

Olympus announced today that it has launched its next-generation Visera Elite III surgical imaging platform in the U.S.

Successful surgery for head and neck squamous cell carcinoma (HNSCC) relies upon complete tumor removal and safe preservation of the fragile nerves in the vicinity. Both are challenging. Fluorescence ...

A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...

Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection ...